Aura Biosciences, Inc. Quarterly Debt-to-equity in % from Q2 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Aura Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q3 2024.
Aura Biosciences, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 14.1 %, a 9.73% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	14.1	-1.52	-9.73%	Sep 30, 2024
Q2 2024	14.2	-2.32	-14.1%	Jun 30, 2024
Q1 2024	14.6	+0.37	+2.6%	Mar 31, 2024
Q4 2023	15.1	+3.44	+29.5%	Dec 31, 2023
Q3 2023	15.6	+6.87	+78.5%	Sep 30, 2023
Q2 2023	16.5	+7.79	+89.4%	Jun 30, 2023
Q1 2023	14.2			Mar 31, 2023
Q4 2022	11.7			Dec 31, 2022
Q3 2022	8.76			Sep 30, 2022
Q2 2022	8.71			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.